封面
市场调查报告书
商品编码
1630684

电子处方笺市场规模、份额、增长分析,按产品类型、按交付方式、按最终用户、按用途、按物质、按专业和按地区 - 行业预测,2025-2032 年

E-Prescription Market Size, Share, Growth Analysis, By Product Type (Solutions, Services), By Delivery Mode (Web-based, Cloud-based), By End-User, By Usage Methods, By Substances, By Specialties, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2023 年全球电子处方笺市场规模价值为 36.6 亿美元,预计将从 2024 年的 46.4 亿美元成长到 2032 年的 310.1 亿美元,预测期内(2025-2032 年)的复合年增长率为 26.8%。

处方错误占医疗保健机构报告的用药相关事故的 72% 以上,引起了全球医疗保健专业人士的极大关注。虽然此类错误很少导致死亡,但它们会给患者带来严重的健康风险,并经常导致对医疗专业人员的法律诉讼。为了解决这个问题,电子处方(e-prescribing)已成为一种有效的解决方案。该技术使医疗保健专业人员能够以电子方式将处方笺发送到药房,最大限度地减少药物交互作用,并透过减少错误来提高患者的安全性。此外,电子处方比传统方法更具成本效益和效率,简化了处方流程。预计各类医疗机构都将采用电子处方系统,这表明对于此项技术在改善医疗品质方面的需求日益增长。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 次要和资料资料
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024 年)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 技术进步
  • 监管格局
  • Start-Ups分析
  • 专利分析

电子处方笺市场规模(依产品类型)

  • 市场概况
  • 解决方案
    • 整合解决方案
    • 独立解决方案
  • 服务
    • 实施服务
    • 支援和维护服务
    • 培训和教育服务

电子处方笺市场规模(以配送方式)

  • 市场概况
  • 基于网路
  • 云端基础
  • 本地

电子处方笺市场规模(按最终用户划分)

  • 市场概况
  • 医院
  • 诊所
  • 药局
  • 门诊手术中心
  • 其他的

电子处方笺市场规模(依用途)

  • 市场概况
  • 手持式
  • 基于计算机的设备

电子处方笺市场规模(按药物成分)

  • 市场概况
  • 管制物质
  • 不受管制的物质

电子处方笺市场规模(依专业划分)

  • 市场概况
  • 肿瘤学
  • 运动医学
  • 神经病学
  • 心臟病学
  • 其他的

电子处方笺市场规模

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲国家
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前 5 家公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采用的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024 年)
  • 主要企业简介
    • 公司简介
    • 产品系列分析
    • 按细分市场分析市场份额
    • 收益与前一年同期比较(2022-2024 年)

主要企业简介

  • CVS Health Corporation(United States)
  • Giant Eagle Inc.(United States)
  • Lloyds Pharmacy Limited(United Kingdom)
  • Rowland Pharmacy(United Kingdom)
  • The Kroger Co.(United States)
  • Walmart Inc.(United States)
  • Cerner Corporation(United States)
  • Allscripts Healthcare Solutions, Inc.(United States)
  • McKesson Corporation(United States)
  • Athenahealth, Inc.(United States)
  • Medtronic plc(Ireland)
  • Siemens Healthineers AG(Germany)
  • GE Healthcare(United States)
  • Philips Healthcare(Netherlands)
  • IBM Watson Health(United States)
  • Oracle Corporation(United States)

结论和建议

简介目录
Product Code: SQMIG35F2007

Global E-Prescription Market size was valued at USD 3.66 billion in 2023 and is poised to grow from USD 4.64 billion in 2024 to USD 31.01 billion by 2032, growing at a CAGR of 26.8% during the forecast period (2025-2032).

Prescription errors represent over 72% of drug-related incidents reported in healthcare settings, raising significant concerns for medical practitioners globally. While these mistakes rarely lead to fatalities, they pose serious health risks for patients and often result in legal actions against healthcare professionals. To combat this issue, electronic prescribing (e-prescribing) has emerged as an effective solution. This technology allows medical providers to electronically send prescriptions to pharmacies, enhancing patient safety by minimizing drug interactions and reducing errors. Additionally, e-prescribing offers a more cost-effective and efficient alternative to traditional methods, streamlining the prescription process. The anticipated growth in the adoption of e-prescribing systems across various medical facilities indicates a rising demand for this technology in enhancing the quality of care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global E-Prescription market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global E-Prescription Market Segmental Analysis

Global E-Prescription Market is segmented by Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties and region. Based on Product Type, the market is segmented into Solutions and Services. Based on Delivery Mode, the market is segmented into Web-based, Cloud-based and On-premise. Based on End-User, the market is segmented into Hospitals, Clinics, Pharmacies, Ambulatory Surgical Centers and Others. Based on Usage Methods, the market is segmented into Handheld and Computer Based Devices. Based on Substances, the market is segmented into Controlled Substances and Non-controlled Substances. Based on Specialties, the market is segmented into Oncology, Sports Medicine, Neurology, Cardiology and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global E-Prescription Market

One of the key drivers of the global e-prescription market is the growing emphasis on eliminating adverse drug events (ADEs) and reducing medical errors in healthcare. Medication mistakes can significantly compromise patient health, making it essential for healthcare providers to utilize robust e-prescribing systems. These systems enable clinicians to access comprehensive patient records, including medical histories, current medications, and diagnoses, thereby enhancing patient safety and minimizing the likelihood of errors. As the incidence of medication errors and drug-related side effects continues to escalate worldwide, the demand for e-prescribing solutions is expected to surge, further propelling market growth.

Restraints in the Global E-Prescription Market

The global e-prescription market faces significant restraints, primarily due to the high expenses associated with the implementation and maintenance of integrated e-prescribing systems. Even though these systems are gaining traction in various clinical environments, their steep costs deter broader acceptance, particularly in developing regions where financial resources are limited. Moreover, the absence of adequate healthcare IT infrastructure in many emerging economies further hinders the growth of this market. As a result, the combination of high investment requirements and insufficient support systems poses a considerable challenge to the widespread adoption of e-prescribing solutions across the globe.

Market Trends of the Global E-Prescription Market

The global e-prescription market is poised for significant growth, driven by the integration of e-prescribing software with Electronic Health Record (EHR) systems. This integration provides numerous advantages, including access to clinical notes, laboratory data, and clinical decision support tools, which standalone systems lack. By enhancing patient medication histories and pharmacy benefits information, EHR-connected e-prescriptions make critical drug data readily available, thereby reducing prescription errors in community healthcare settings. Additionally, increasing government initiatives to implement integrated EHR systems in hospitals further propel market expansion, highlighting the crucial role of technology in improving patient safety and healthcare efficiency.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Advancement
  • Regulatory Landscape
  • Startup Analysis
  • Patent Analysis

Global E-Prescription Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Solutions
    • Integrated Solutions
    • Standalone Solutions
  • Services
    • Implementation Services
    • Support & Maintenance Services
    • Training & Education Services

Global E-Prescription Market Size by Delivery Mode & CAGR (2025-2032)

  • Market Overview
  • Web-based
  • Cloud-based
  • On-premise

Global E-Prescription Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Clinics
  • Pharmacies
  • Ambulatory Surgical Centers
  • Others

Global E-Prescription Market Size by Usage Methods & CAGR (2025-2032)

  • Market Overview
  • Handheld
  • Computer Based Devices

Global E-Prescription Market Size by Substances & CAGR (2025-2032)

  • Market Overview
  • Controlled Substances
  • Non-controlled Substances

Global E-Prescription Market Size by Specialties & CAGR (2025-2032)

  • Market Overview
  • Oncology
  • Sports Medicine
  • Neurology
  • Cardiology
  • Others

Global E-Prescription Market Size & CAGR (2025-2032)

  • North America (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
    • US
    • Canada
  • Europe (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • CVS Health Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Giant Eagle Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lloyds Pharmacy Limited (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rowland Pharmacy (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • The Kroger Co. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Walmart Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cerner Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allscripts Healthcare Solutions, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • McKesson Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Athenahealth, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips Healthcare (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IBM Watson Health (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oracle Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations